by admin | Oct 17, 2023 | Pharma
Italian-Swiss biotechnology company Philogen and Sun Pharmaceutical announced positive results from the Phase III “Pivotal” trial of Nidlegy on locally advanced melanoma. Nidlegy is Philogen’s prorpietary product to treat skin cancer and is being investigated for the...
